A Study of Outcomes in Chinese Patients Treated With Anifrolumab Who Have Active Mod-severe Systemic Lupus Erythematosus
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Anifrolumab
Related studies linked through entity extraction aliases.
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- PHASE3
Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.
- Status
- RECRUITING
- Phase
- N/A
Anifrolumab Malignancy and Serious Infections Study
- Status
- RECRUITING
- Phase
- N/A
The Anifrolumab PRIM Program
- Status
- RECRUITING
- Phase
- N/A
Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
- Status
- RECRUITING
- Phase
- N/A
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
- Status
- RECRUITING
- Phase
- PHASE4
Anifrolumab for Hidradenitis Suppurativa
- Status
- COMPLETED
- Phase
- PHASE2
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Status
- RECRUITING
- Phase
- PHASE3
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
- Status
- RECRUITING
- Phase
- PHASE2
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3